CBIO

CRESCENT BIOPHARMA, INC.

Healthcare · Biotechnology

$57.58 sample

-0.38 (-0.66%) 1D

Market cap

$61.8B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-08

Alerts

8

Price$57.58 +20.38% 3M daily closessample

57.9647.83

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: 10% owner
Sep 22INSInsider sell: Director
Sep 11INSInsider buy: General Counsel
Sep 08SEC10-Q filed
Sep 03INSInsider sell: 10% owner
Aug 28INSInsider sell: EVP, Operations
Aug 21INSInsider sell: Chief Financial Officer
Aug 18INSInsider sell: EVP, Operations

Sign up to see the real CBIO record →

Company facts

SEC EDGAR registration

Name: CRESCENT BIOPHARMA, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -1sample, -100 to +100
Reporting currency: USD

Who is positioning in CBIO

sample

Insiders: 27 insider transactions over 90 days, net selling, $699.3M
Congress: No member trades over 90 days
Institutions · 13F: 17 funds hold $801.0M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.0B +19.7% y/y

Q4 2024Q3 2026

Inventory$1.8B +17.9% y/y

Q4 2024Q3 2026

Accounts receivable$1.3B +18.0% y/y

Q4 2024Q3 2026

Total debt$3.4B +3.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $55.1B +16.4% 3M
Sample peer B: $51.5B +8.4% 3M
Sample peer C: $35.0B +2.6% 3M
Sample peer D: $52.3B +11.2% 3M
Sample peer E: $18.7B +5.0% 3M